Cargando…
Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000912/ https://www.ncbi.nlm.nih.gov/pubmed/35434653 http://dx.doi.org/10.1016/S2665-9913(22)00099-6 |
_version_ | 1784685552949264384 |
---|---|
author | Goulenok, Tiphaine Delaval, Laure Delory, Nicole François, Chrystelle Papo, Thomas Descamps, Diane Ferré, Valentine Marie Sacré, Karim |
author_facet | Goulenok, Tiphaine Delaval, Laure Delory, Nicole François, Chrystelle Papo, Thomas Descamps, Diane Ferré, Valentine Marie Sacré, Karim |
author_sort | Goulenok, Tiphaine |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9000912 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90009122022-04-12 Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases Goulenok, Tiphaine Delaval, Laure Delory, Nicole François, Chrystelle Papo, Thomas Descamps, Diane Ferré, Valentine Marie Sacré, Karim Lancet Rheumatol Comment Elsevier Ltd. 2022-07 2022-04-11 /pmc/articles/PMC9000912/ /pubmed/35434653 http://dx.doi.org/10.1016/S2665-9913(22)00099-6 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Comment Goulenok, Tiphaine Delaval, Laure Delory, Nicole François, Chrystelle Papo, Thomas Descamps, Diane Ferré, Valentine Marie Sacré, Karim Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases |
title | Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases |
title_full | Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases |
title_fullStr | Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases |
title_full_unstemmed | Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases |
title_short | Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases |
title_sort | pre-exposure anti-sars-cov-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000912/ https://www.ncbi.nlm.nih.gov/pubmed/35434653 http://dx.doi.org/10.1016/S2665-9913(22)00099-6 |
work_keys_str_mv | AT goulenoktiphaine preexposureantisarscov2monoclonalantibodiesinseverelyimmunocompromisedpatientswithimmunemediatedinflammatorydiseases AT delavallaure preexposureantisarscov2monoclonalantibodiesinseverelyimmunocompromisedpatientswithimmunemediatedinflammatorydiseases AT delorynicole preexposureantisarscov2monoclonalantibodiesinseverelyimmunocompromisedpatientswithimmunemediatedinflammatorydiseases AT francoischrystelle preexposureantisarscov2monoclonalantibodiesinseverelyimmunocompromisedpatientswithimmunemediatedinflammatorydiseases AT papothomas preexposureantisarscov2monoclonalantibodiesinseverelyimmunocompromisedpatientswithimmunemediatedinflammatorydiseases AT descampsdiane preexposureantisarscov2monoclonalantibodiesinseverelyimmunocompromisedpatientswithimmunemediatedinflammatorydiseases AT ferrevalentinemarie preexposureantisarscov2monoclonalantibodiesinseverelyimmunocompromisedpatientswithimmunemediatedinflammatorydiseases AT sacrekarim preexposureantisarscov2monoclonalantibodiesinseverelyimmunocompromisedpatientswithimmunemediatedinflammatorydiseases |